Plazma Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.12 M
- Company Age 40 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -100.00%
- Profit Growth 89.20%
- Ebitda 92.60%
- Net Worth -0.99%
- Total Assets -0.01%
About Plazma Laboratories
Plazma Laboratories Pvt Ltd (PLPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 December 1984 and has a history of 40 years and two months. Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.12 M, as per Ministry of Corporate Affairs (MCA) records.
Smita Hingu and Kartik Parikh serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232MP1984PTC002672
-
Company No.
002672
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Dec 1984
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Plazma Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Smita Hingu
|
Director | 30-May-2018 | Current |
|
Kartik Parikh
|
Director | 07-Jan-2015 | Current |
Financial Performance of Plazma Laboratories.
Plazma Laboratories Pvt Ltd, for the financial year ended 2022, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial improvement in profitability, with a 89.2% increase in profit. The company's net worth dipped by a decrease of 0.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Plazma Laboratories?
Unlock access to Plazma Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Passion Indulge Private LimitedSmita Hingu and Kartik Parikh are mutual person
-
Wiscon Pharmaceuticals Private LimitedKartik Parikh is a mutual person
-
Plethico Laboratories Pvt LtdSmita Hingu and Kartik Parikh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Plazma Laboratories?
Unlock and access historical data on people associated with Plazma Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Plazma Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Plazma Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
